A case is presented, in which the extrapyramidal side effects of depot pipotiazine lasted well over 6 months, and possibly the therapeutic effect for almost 12 months following the last injection. The case report illustrates the need for flexible individualized dosage schedules, similar to other neuroleptics.
References
1.
St. LaurentJ., CarleR., DumaisB., DomingueD.Monthly intermittent chemotherapy of chronic schizophrenic outpatients with pipothiazine palmitate.Can Psychiatr Assoc J1974; 19: 583–590.
2.
AlbertJ.M., ElieR., CooperS.F.Long-term double-blind evaluation of pipotiazine palmitate and fluphenazine enanthate.Curr Ther Res1980; 27: 897–907.
3.
SinghA.N., SaxenaB.A comparative study of prolonged action (depot) neuroleptics: pipotiazine palmitate versus fluphenazine enanthate in chronic schizophrenic patients.Curr Ther Res1979; 25: 121–132.
4.
VilleneuveA., FontaineP.A near decade experience with pipotiazine palmitate in chronic schizophrenia.Curr Ther Res1980; 27: 411–418.
5.
BurchE.A., AydF.J.Depot pipotiazine 1970–1982: a review.J Clin Psychiatr1983; 44: 242–247.
